

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CTLT | NYSE | USD | Real-time | |
0C8 | Frankfurt | EUR | Delayed | |
CTLT-RM | Moscow | RUB | Real-time |
Catalent, Inc. is a provider of development and manufacturing solutions for drug, cell and gene therapies biologics, vaccines, and consumer health products. The Company’s segments include Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. Its Biologics segment provides development and manufacturing for protein, plasmid DNA mRNA, cell therapy, viral vaccines and viral-based gene therapies. Its Softgel and Oral Technologies segment provide formulation, development, and manufacturing services for soft capsules, as well as large-scale manufacturing of oral solid dose forms. Its Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. Its Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for, drugs, biologics and clinical trials.
Name | Age | Since | Title |
---|---|---|---|
Rolf A. Classon | 77 | 2014 | Independent Director |
Madhavan Balachandran | 71 | 2017 | Independent Director |
Michael J. Buckley | 61 | 2015 | Member of Advisory Board |
Donald Eugene Morel | 64 | 2015 | Independent Director |
Edward R. Robinson | - | 2015 | Member of Advisory Board |
John J. Greisch | 67 | 2018 | Independent Director |
Christa Kreuzburg | 63 | 2018 | Independent Director |
J. Martin Carroll | 73 | 2015 | Independent Lead Director |
John R. Chiminski | 58 | 2009 | Executive Chair of the Board |
Barry C. Buckland | 74 | 2015 | Member of Advisory Board |
Daniel R. Marshak | 65 | 2015 | Member of Advisory Board |
Gregory T. Lucier | 58 | 2015 | Independent Director |
Jack L. Stahl | 69 | 2014 | Independent Director |
Carolyn R. Bertozzi | 55 | 2015 | Member of Scientfic & Advisory Board |
Rosemary A. Crane | 62 | 2018 | Independent Director |
Alessandro Maselli | 50 | 2016 | CEO & Director |
Matthew R. Stober | 55 | - | Member of the Biologics Advisory Board |
Karen A. Flynn | 60 | 2020 | Director |
David E. Schaffer | 53 | 2019 | Member of the Biologics Advisory Board |
Michael J. Barber | 62 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review